Journal of Oral Science Research ›› 2022, Vol. 38 ›› Issue (10): 981-985.DOI: 10.13701/j.cnki.kqyxyj.2022.10.017

Previous Articles     Next Articles

Clinical Analysis of 14 Cases of Ameloblastic Carcinoma

YUAN Zhuang1,2, LUO Hao2, WU Kailiu3, HE Jie3*, MENG Jian1,2*   

  1. 1. Department of Stomatology, Xuzhou Clinical College of Xuzhou Medical University, Xuzhou 221004, China;
    2. School of Stomatology, Xuzhou Medical University, Xuzhou 221000, China;
    3. Department of Oral and Maxillofacial-Head and Neck Surgery, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology; National Clinical Research Center of Stomatology, Shanghai 200011, China
  • Received:2021-09-17 Online:2022-10-28 Published:2022-10-20

Abstract: Objective: To explore the clinical characteristics, diagnosis, and treatment of ameloblastic carcinoma (AC) by analyzing clinical cases and reviewing the literature. Methods: The clinical data of 14 patients with AC were retrospectively analyzed. Results: There were 10 male and 4 female patients included in this study, with a male-to-female ratio of 2.5∶1. Their ages ranged from 15 to 71 years and the mean age was 40.9 years. Six patients' lesion location was maxilla and 8 patients' was mandible, and the maxilla-to-mandible ratio was 0.75∶1. All patients were subjected to surgical resection and followed-up for 0.5-7 years to record recurrence. There were 9 recurrences in the case series, of which 1 had cervical lymph node metastasis, and 2 had lung metastasis after surgery. Conclusion: AC is a rare neoplasm of the odontogenic epithelium. Secondary AC is mostly caused by repeated surgical intervention. Recurrence rate of AC is closely related to lesion location and treatment. At present, extended surgical resection is still the preferred treatment and postoperative long-time followed-up is necessary.

Key words: ameloblastic carcinoma, clinical manifestations, diagnosis, treatment